Full-size Left-side Hidden

1. Boyd AS, Neldner KH: Lichen planus. J Am Acad Dermatol  1991; 25:593-619.

2. Chuang T-Y, Stitle L, Brashear R, Lewis C: Hepatitis C virus and lichen planus: a case-control study of 340 patients. J Am Acad Dermatol  1999; 41:787-789.

3. Nagao Y, Kameyama T, Sata M: Hepatitis C virus RNA detection in oral lichen planus tissue [letter]. Am J Gastroenterol  1998; 93:850.

4. Carrozzo M, Francia Di Celle P, Gandolfo S, et al: Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol  2001; 144:803-808.

5. Pilli M, Zerbini A, Vescovi P, et al: Oral lichen planus pathogenesis: a role for the HCV-specific cellular immune response. Hepatology  2002; 36:1446-1452.

5a. De Vries HJ, van Marle J, Teunissen MB, et al: Lichen planus is associated with human herpesvirus type 7 replication and infiltration of plasmacytoid dendritic cells. Br J Dermatol  2006; 154:361-364.

5b. De Vries HJ, Teunissen MB, Zorgdrager F, et al: Lichen planus remission is associated with a decrease of human herpes virus type 7 protein expression in plasmacytoid dendritic cells. Arch Dermatol Res  2007; 299:213-219.

6. Requena L, Kutzner H, Escalonilla P, et al: Cutaneous reactions at sites of herpes zoster scars: an expanded spectrum. Br J Dermatol  1998; 138:161-168.

7. Al-Khenaizan S: Lichen planus occurring after hepatitis B vaccination: a new case. J Am Acad Dermatol  2001; 45:614-615.

8. Halevy S, Shai A: Lichenoid drug eruption. J Am Acad Dermatol  1993; 29:249-255.

9. Shiohara T, Moriya N, Mochizuki T, Nagashima M: Lichenoid tissue reaction (LTR) induced by local transfer of la-reactive T-cell clonesII. LTR by epidermal invasion of cytotoxic lymphokine-producing autoreactive T cells. J Invest Dermatol  1987; 89:8-14.

10. Shiohara T, Moriya N, Nagashima M: Induction and control of lichenoid tissue reactions. Springer Semin Immunopathol  1992; 13:369-385.

11. Sugerman PB, Satterwhite K, Bigby M: Autocytotoxic T-cell clones in lichen planus. Br J Dermatol  2000; 142:449-456.

12. Yasukawa M, Ohminami A, Arai J, et al: Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. Blood  2000; 95:2352-2355.

13. Spandau U, Toksoy A, Goebeler M, et al: MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions. J Invest Dermatol  1998; 111:1003-1009.

14. Mignogna MD, Muzio LL, Russo LL, et al: Oral lichen planus: different clinical features in HCV-positive and HCV-negative patients. Int J Dermatol  2000; 39:134-139.

15. Goldstein AT, Metz A: Vulvar lichen planus. Clin Obstet Gynecol  2005; 48:818-823.

16. Van den Haute V, Antoine JL, Lachapelle JM: Histopathological discriminant criteria between lichenoid drug eruptions and idiopathic lichen planus: retrospective study on selected samples. Dermatologica  1989; 179:10-13.

17. Córdoba S, Fraga J, Bartolomé B, et al: Giant cell lichenoid dermatitis with herpes zoster scars in a bone marrow recipient. J Cutan Pathol  2000; 27:255-257.

18. Orteuu CH, Buchanan JAG, Hutchison I, et al: Systemic lupus erythematosus presenting with oral mucosal lesions: easily missed. Br J Dermatol  2001; 144:1219-1223.

19. Byrd JA, Davis MDP, Rogers III RS, et al: Recalcitrant symptomatic vulvar lichen planusResponse to topical tacrolimus. Arch Dermatol  2004; 140:715-720.

19a. Byrd JA, Davis MDP, Bruce AJ, et al: Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol  2004; 140:1508-1512.

20. Cribier B, Frances C, Chosidow O: Treatment of lichen planus. Arch Dermatol  1998; 134:1521-1530.

21. Büyük AY, Kavala M: Oral metronidazole treatment of lichen planus. J Am Acad Dermatol  2000; 43:260-262.

21a. Torti DC, Jorizzo JL, McCarty MA: Oral lichen planus. Arch Dermatol  2007; 143:511-515.

22. Ho VC, Gupta AK, Nickoloff FJ, Vorhess JJ: Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol  1990; 22:64-68.

23. Mirmirani P, Willey A, Price VH: Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol  2003; 49:667-671.

24. Becherel PA, Bussel A, Chosidow O, et al: Extracorporeal photochemotherapy for chronic erosive lichen planus. Lancet  1998; 351:805.

25. Trehan M, Taylar CR: Low-dose excimer 308-nm laser for the treatment of oral lichen planus. Arch Dermatol  2004; 140:415-420.

26. Patrizi A, Nevi I, Fiorentini C, et al: Lichen striatus: clinical and laboratory features of 115 children. Pediatr Dermatol  2004; 21:197-204.

27. Zhang Y, McNutt NS: Lichen striatusHistological, immunohistochemical, and ultrastructural study of 37 cases. J Cutan Pathol  2001; 28:65-71.

28. Kano Y, Inaoka M, Shiohara T: Superficial lymphangitis with interface dermatitis occurring shortly after a minor injury: possible involvement of a bacterial infection and contact allergens. Dermatology  2002; 203:217-220.

29. Kano Y, Shiohara T, Yagita A, Nagashima M: Erythema nodosum, lichen planus and lichen nitidus in Crohn's disease: report of a case and analysis of T cell receptor V gene expression in the cutaneous and intestinal lesions. Dermatology  1995; 190:59-63.

30. Lapins NA, Willoughby C, Helwig EB: Lichen nitidus. Cutis  1978; 21:634-637.

31. Shiohara T, Moriya N, Tanaka Y, et al: Immunopathological study of lichenoid skin diseases: correlation between HLA-DR-positive keratinocytes or Langerhans cells and epidermotropic T cells. J Am Acad Dermatol  1988; 18:67-74.

32. Smoller BR, Flynn TC: Immunohistochemical examination of lichen nitidus suggests that it is not a localized papular variant of lichen planus. J Am Acad Dermatol  1992; 27:232-236.

33. Park JH, Choi YL, Kim WS, et al: Treatment of generalized lichen nitidus with narrowband ultraviolet B. J Am Acad Dermatol  2006; 54:545-546.

34. Kano Y, Otake Y, Shiohara T: Improvement of lichen nitidus after topical dinitrochlorobenzene application. J Am Acad Dermatol  1998; 39:305-308.

35. Mollderm JJ, Lee PP, Wang C, et al: Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med  2000; 6:1018-1023.

36. Gilliam AC: Update on graft versus host disease. J Invest Dermatol  2003; 123:251-257.

37. Johnson ML, Farmer ER: Graft-versus-host reactions in dermatology. J Am Acad Dermatol  1998; 38:369-392.

38. Couriel D, Saliba R, Hicks K, et al: Tumor necrosis factor- a blockade for the treatment of acute GVHD. Blood  2004; 104:649-654.

39. Nagler R, Marmary Y, Krausz Y, et al: Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant  1996; 17:219-224.

40. Lerner KG, Kao GF, Storb R, et al: Histopathology of graft-vs-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc  1974; 6:367-371.

41. Shulman HM, Kleiner D, Lee SJ, et al: Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIPathology Working Group Report. Biol Blood Marrow Transplant  2006; 12:31-47.

42. Horn AD: Acute cutaneous eruptions after marrow ablation: roses by other names. J Cutan Pathol  1994; 21:385-392.

43. Vogelsang GB: How I treat chronic graft-versus-host disease. Blood  2001; 97:1196-1201.

44. Grundmann-Kollmann M, Behrens S, Gruss C, et al: Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 therapy. J Am Acad Dermatol  2000; 42:134-136.

45. Canninga-van Dijk M, van der Straaten HM, R Fijnheer, et al: Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood  2004; 104:2603-2606.

46. Pinkus H: Lichenoid tissue reactions: a speculative review of the clinical spectrum of epidermal basal cell damage with special reference to erythema dyschromicum perstans. Arch Dermatol  1973; 107:840-846.

47. Mizukawa Y, Shiohara T: Fixed drug eruption presenting as erythema dyschromicum perstans: a flare without taking any medications. Dermatology  1998; 197:383-385.

48. Masouye I, J-H Saurat: Keratosis lichenoids chronica: the centenary of another Kaposi's disease. Dermatology  1995; 191:188-192.

49. Bedi TR: Summertime actinic lichenoid eruption. Dermatologica  1978; 157:115-125.

50. Isaacson D, Turner ML, Elgart ML: Summertime actinic lichenoid eruption (lichen planus actinicus). J Am Acad Dermatol  1981; 4:404-411.

51. Hussain K: Summertime actinic lichenoid eruption, a distinct entity, should be termed actinic lichen nitidus. Arch Dermatol  1998; 134:1302-1303.